Evidence map›Paper›PMID 37632339›Full record

ArticleEuropean journal of heart failure2023

Sex differences in long-term outcomes following acute heart failure hospitalization: Findings from the Get With The Guidelines-Heart Failure registry.

Neil Keshvani, Sonia Shah, Iyanuoluwa Ayodele, Karen Chiswell, Brooke Alhanti, Larry A Allen, Stephen J Greene, Clyde W Yancy, Windy W Alonso, Harriette Gc Van Spall and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in European journal of heart failure, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. 2024 update in heart failure.ESC heart failure · 2025
    Review
  14. Article
  15. Comorbidities and determinants of health on heart failure guideline-directed medical therapy adherence: All of us.International journal of cardiology. Cardiovascular risk and prevention · 2024
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 3 countries.

Neil KeshvaniDivision of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0001-6890-8670
Sonia ShahDivision of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.
Iyanuoluwa AyodeleDuke Clinical Research Institute, Durham, NC, USA.
Karen ChiswellDuke Clinical Research Institute, Durham, NC, USA.
Brooke AlhantiDuke Clinical Research Institute, Durham, NC, USA.
Larry A AllenDivision of Cardiology, Department of Internal Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
Stephen J GreeneDuke Clinical Research Institute, Durham, NC, USA.
Clyde W YancyDivision of Cardiology, Northwestern University, Chicago, IL, USA.
Windy W AlonsoCollege of Nursing, University of Nebraska Medical Center, Omaha, NE, USA.
Harriette Gc Van SpallPopulation Health Research Institute, Hamilton, ONT, Canada.
Gregg C FonarowDavid Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Paul A HeidenreichStanford University, Palo Alto, CA, USA.
Ambarish PandeyDivision of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.
Clinical Research Institute · USSouthwestern Medical Center · USDuke University · USNebraska Medical Center · USNorthwestern University · USPalo Alto University · USPopulation Health Research Institute · CAUniversity of California, Los Angeles · USUniversity of Colorado Denver · US

Funding

Training in Cardiovascular ResearchT32HL125247 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI JOSEPH A HILL · 2015 to 2026
$4.3M
Polypill strategy for the evidence-based management of heart failure with reduced ejection fraction in an underserved patient populationR01MD017529 · NIMHD · UT SOUTHWESTERN MEDICAL CENTER · PI PANDEY, AMBARISH, WANG, THOMAS J. · 2022 to 2025
$2.9M
Evaluation of Racial Differences in Cardiorespiratory Fitness Decline with Aging & Underlying Biological MechanismsR03AG067960 · NIA · UT SOUTHWESTERN MEDICAL CENTER · PI PANDEY, AMBARISH · 2020 to 2021
$327k
NHLBI NIH HHS T32 HL125247NIA NIH HHS R03 AG067960NIMHD NIH HHS R01 MD017529
6 · The paper itself

Abstract

aimsSex differences in long-term outcomes following hospitalization for heart failure (HF) across ejection fraction (EF) subtypes are not well described. In this study, we evaluated the risk of mortality and rehospitalization among males and females across the spectrum of EF over 5 years of follow-up following an index HF hospitalization event. METHODS AND

resultsPatients hospitalized with HF between 1 January 2006 and 31 December 2014 from the American Heart Association's Get With The Guidelines-Heart Failure registry with available 5-year follow-up using Medicare Part A claims data were included. The association between sex and risk of mortality and readmission over a 5-year follow-up period for each HF subtype (HF with reduced EF [HFrEF, EF ≤40%], HF with mildly reduced EF [HFmrEF, EF 41-49%], and HF with preserved EF [HFpEF, EF >50%]) was assessed using adjusted Cox models. The effect modification by the HF subtype for the association between sex and outcomes was assessed by including multiplicative interaction terms in the models. A total of 155 670 patients (median age: 81 years, 53.4% female) were included. Over 5-year follow-up, males and females had comparably poor survival post-discharge; however, females (vs. males) had greater years of survival lost to HF compared with the median age- and sex-matched US population (HFpEF: 17.0 vs. 14.6 years; HFrEF: 17.3 vs. 15.1 years; HFmrEF: 17.7 vs. 14.6 years for age group 65-69 years). In adjusted analysis, females (vs. males) had a lower risk of 5-year mortality (adjusted hazard ratio [aHR] 0.89, 95% confidence interval [CI] 0.87-0.90, p < 0.0001), and the risk difference was most pronounced among patients with HFrEF (aHR 0.87, 95% CI 0.85-0.89; p

conclusionsWhile females (vs. males) had lower adjusted mortality, females experienced a significantly greater loss in survival time than the median age- and sex-matched US population and had a greater risk of rehospitalization over 5 years following HF hospitalization.

Indexed as

Heart FailureAftercareAgedAged, 80 and overFemaleHospitalizationHumansMaleMedicarePatient DischargePrognosisRegistriesSex CharacteristicsStroke VolumeUnited StatesEjection fractionHeart failureOutcomesSex differences

Identifiers

PMID37632339
PMCPMC11069419
OpenAlexW4386191518

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.